CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 121 enrolled
Drug / intervention
Insulclock with feedback +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03224234
NCT03224234N/ACompleted
CompareCT.gov

A Randomized Study to Evaluate the Efficacy of Insulclock® in Patients With Uncontrolled Type 2 Diabetes

Emory University·interventional·Posted Jul 21, 2017·Updated Jan 22, 2021

In Brief

A clinical study evaluating Insulclock with feedback and Insulclock without feedback for Diabetes. Completed, enrolled 121 participants across 1 site.

Detailed Summary

Poor adherence to insulin regimens is reported in up to two-third of patients with diabetes; thus it is important to identify patients at risk and to develop strategies and tools to increase adherence to prescribed insulin regimens. This study will evaluate the efficacy of Insulclock® - small electronic device to help track date, time and dosage of the last injection, type of insulin used and temperature, with an alarm system to prevent insulin omissions and mistiming.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes
CountriesUnited States
CollaboratorsInsulcloud S.L.

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedJul 21, 2017
Enrollment StartNov 29, 2017
Primary CompletionSep 18, 2019
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 8.9 years ago

Interventions

Insulclock with feedbackdevice

Daily information on a smartphone on insulin administration (time and dosing) as well as reminders in the event of missing doses.

Insulclock without feedbackdevice

Not feedback on insulin administration.